BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30827643)

  • 1. A study on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides.
    Du Z; Liu J; Zhang T; Yu Y; Zhang Y; Zhai J; Huang H; Wei S; Ding L; Liu B
    Food Chem; 2019 Jul; 286():530-536. PubMed ID: 30827643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Du Z; Liu J; Zhang H; Wu X; Zhang B; Chen Y; Liu B; Ding L; Xiao H; Zhang T
    J Agric Food Chem; 2019 Nov; 67(45):12511-12519. PubMed ID: 31626537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three water-soluble polyphosphate tripolyphosphate, phytic acid, and sodium hexametaphosphate as crosslinking agents in chitosan nanoparticle formulation.
    Sang Z; Qian J; Han J; Deng X; Shen J; Li G; Xie Y
    Carbohydr Polym; 2020 Feb; 230():115577. PubMed ID: 31887915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and biological activity studies of resveratrol loaded ionically cross-linked chitosan-TPP nanoparticles.
    Wu J; Wang Y; Yang H; Liu X; Lu Z
    Carbohydr Polym; 2017 Nov; 175():170-177. PubMed ID: 28917853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using different chitosan to tripolyphosphate (CS:TPP) ratios.
    Hejjaji EMA; Smith AM; Morris GA
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1610-1617. PubMed ID: 30282010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
    Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
    J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted drug delivery of Sunitinib Malate to tumor blood vessels by cRGD-chiotosan-gold nanoparticles.
    Saber MM; Bahrainian S; Dinarvand R; Atyabi F
    Int J Pharm; 2017 Jan; 517(1-2):269-278. PubMed ID: 27956189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate loading in chitosan nanoparticles at a novel pH: Response surface modeling, optimization and characterization.
    Hashad RA; Ishak RA; Geneidi AS; Mansour S
    Int J Biol Macromol; 2016 Oct; 91():630-9. PubMed ID: 27283234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides.
    Du Z; Liu J; Zhang T; Yu Y; Zhang Y; Zhai J; Huang H; Wei S; Ding L; Liu B
    Data Brief; 2020 Feb; 28():104841. PubMed ID: 31832532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks.
    Hashad RA; Ishak RA; Fahmy S; Mansour S; Geneidi AS
    Int J Biol Macromol; 2016 May; 86():50-8. PubMed ID: 26783636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
    Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
    Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil monodispersed chitosan microspheres: Microfluidic chip fabrication with crosslinking, characterization, drug release and anticancer activity.
    He T; Wang W; Chen B; Wang J; Liang Q; Chen B
    Carbohydr Polym; 2020 May; 236():116094. PubMed ID: 32172896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
    Raja MA; Katas H; Jing Wen T
    PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
    Motiei M; Kashanian S
    Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan/sodium tripolyphosphate nanoparticles as efficient vehicles for enhancing the cellular uptake of fish-derived peptide.
    Zhao Y; Du W; Wu H; Wu M; Liu Z; Dong S
    J Food Biochem; 2019 Feb; 43(2):e12730. PubMed ID: 31353647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the osteogenesis of rat mesenchymal stem cells by chitosan-based-microRNA nanoparticles.
    Wu G; Feng C; Hui G; Wang Z; Tan J; Luo L; Xue P; Wang Q; Chen X
    Carbohydr Polym; 2016 Mar; 138():49-58. PubMed ID: 26794737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate:
    Aljaeid BM; El-Say KM; Hosny KM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.